Hyperbaric Oxygen Therapy in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss
Article Sidebar
Main Article Content
Abstract
Backgrounds and objectives
Idiopathic sudden sensorineural hearing loss (ISSNHL) is an entity whose diagnosis and treatment remain controversial to date. Various modalities of treatment have been tried with varying degrees of success. Hyperbaric oxygen therapy (HBOT) is a recent modality of treatment for this condition which acts by improving cochlear microcirculation. The objective of this study was to evaluate the effect of HBOT in improving hearing loss and secondary symptoms patients with ISSNHL.
Methods
This prospective study was undertaken over a 6 month period from the Department of Otorhinolaryngology in a tertiary referral hospital in eastern India. 48 consecutive newly diagnosed ISSNHL patients were included in this study. The patients were subjected to HBOT at 2 A.T.A (Atmosphere Absolute) for an hour over 45 days. Hearing status and secondary symptoms as assessed by clinical tests, pure tone audiogram were analysed before and after HBOT.
Results
Males comprised 62.5% (30/48) of our study population, mean age of the population was 49.3 ± 13.4 years. 45/48 patients (93.7%) had unilateral ISSNHL, while 3 (6.3%) had bilateral ISSNHL. Average hearing loss in the affected ear before and after treatment was 79.96dBHL and 62.27dBHL respectively. The most common secondary clinical feature was tinnitus (27/48, 56.3%), followed by vertigo (24/48, 50%), aural fullness (15/48, 31.25%) and nystagmus (5/48, 10.41%). After treatment tinnitus and vertigo were showed marked improvement; (22/27, 81.48%) and (18/24, 75%). 5 out of 15 (33.34%) patients showed reduced aural fullness. There was no improvement in patients suffering from nystagmus.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A doubleblind clinical study. Archives of Otolaryngology 1980; 106: 772–6
Wu CS, Lin HC, Chao PZ. Sudden sensorineural hearing loss: Evidence from Taiwan. Audiology and Neurootology 2006; 11:151–6
Tompach PC, Lew D, Stoll JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surg. 1997;26(2):82-86.
Crane RA, Camilon M, Ngyuen S, Meyer TA. Steroids for Treatment of Sudden Sensorineural Hearing Loss: A Meta-Analysis of Randomized Controlled Trials.Laryngoscope 2015; 125(1):209-17.
Shaikh JA, Roehm PC. Does addition of antiviral medication to high-dose corticosteroid therapy improve hearing recovery following idiopathic sudden sensorineural hearing loss? Laryngoscope 2011;121(11):2280.
Capuano L, Cavaliere M, Parente G, Damiano A, Pezzuti G, Lopardo D, Iemma M. Hyperbaric oxygen for idiopathic sudden hearing loss:Is the routine application helpful? Acta Otolaryngol. 2015; 135(7):692-7.
Yacono D, Allen MW. Hyperbaric oxygen therapy (HBO2) as an adjunct in the treatment of idiopathic sudden sensorineural hearing loss(ISSHL)--A case report on two patients. Undersea Hyperb Med. 2014; 41(5):401-5.
Gaitanou K, Fildissis G, Vavasis P, Kalentzos V, Baltopoulos G. Management of sudden hearing loss with hyperbaric oxygen therapy. Undersea Hyperb Med. 2014; 41(5):363-70.
Cvorovic L, Jovanovic MB, Milutinovic Z, Arsovic N, Djeric D. Randomized prospective trial of hyperbaric oxygen therapy and intratympanic steroid injection as salvage treatment of sudden sensorineural hearing loss. Otol Neurotol. 2013; 34(6):1021-6.
Bennett MH, Kertesz T, Perleth M, Yeung P, Lehm JP. Hyperbaric oxygen for idiopathic sudden sensorineural hearing loss and tinnitus. Cochrane Database Syst Rev. 2012; 17:10:CD004739
Filipo R, Attanasio G, Viccaro M, Russo FY, et al. Hyperbaric oxygen therapy with short duration intratympanic steroid therapy for sudden hearing loss. Acta Otolaryngol.2012; 132(5):475-81.doi 10.3109/00016489.2011.647360
Holy R, Navara M, Dosel P, Fundova P, Prazenica P, Hahn A. Hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss (ISSNHL) in association with combined treatment. Undersea Hyperb Med. 2011; 38(2):137-42
Alimoglu Y, Inci E, Edizer DT, Ozdilek A, Aslan M. Efficacy comparison of oral steroid, intratympanic steroid, hyperbaric oxygen and oral steroid + hyperbaricoxygen treatments in idiopathic sudden sensorineural hearing loss cases. Eur Arch Otorhinolaryngol. 2011;268(12):1735-41. doi: 10.1007/s00405-011-1563-5